Immunitybio (IBRX) has had the highest return since January 1, 2026 by a mid-cap US stock, returning 471.8%.
| ASSET | % RETURN |
|---|---|
Immunitybio (IBRX) | 471.78% |
Erasca (ERAS) | 266.85% |
Alumis (ALMS) | 187.41% |
Ultra Clean (UCTT) | 175.29% |
Hycroft Mining (HYMC) | 91.4% |
Valaris (VAL) | 89.94% |
IPG Photonics (IPGP) | 80.73% |
Arcellx (ACLX) | 75.03% |
FormFactor (FORM) | 73.86% |
Powell Industries (POWL) | 72.66% |
Frontline (FRO) | 72.18% |
Fastly, Inc Class A Common Stock (FSLY) | 71.06% |
Vicor (VICR) | 70.73% |
USA Rare Earth (USAR) | 66.04% |
Americas Silver (USAS) | 65.46% |
Acm Research (ACMR) | 65.27% |
Noble (NE) | 63.48% |
Solstice Advanced Materials (SOLS) | 63.19% |
Neogen (NEOG) | 61.9% |
Power Solutions International, Inc Common Stock (PSIX) | 61.4% |
Viavi Solutions (VIAV) | 61.39% |
Oceaneering International (OII) | 60.75% |
Sprott (SII) | 58.88% |
Cognex (CGNX) | 58.88% |
DHT (DHT) | 58.18% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
